New Covid-19 variant detected in France not a threat yet, says WHO

The new Covid-19 variant called B.1.640 has so far been identified in less than 1 per cent of the samples sequenced in France, the World Health Organization (WHO) said

Coronavirus
Photo: Shutterstock
IANS Geneva
2 min read Last Updated : Jan 07 2022 | 1:34 PM IST

The new Covid-19 variant called B.1.640, which was detected by French researchers and is probably of Cameroonian origin, is not "circulating widely at the moment" and has so far been identified in less than 1 per cent of the samples sequenced in France, the World Health Organization (WHO) said.

The strain is also known as the 'IHU' variant because it was first identified by academics at the IHU Mediterranee Infection institute in Marseille, France, reports Xinhua news agency.

At a press briefing on THursday, Maria van Kerkhove, technical lead for the WHO's Health Emergencies Program, said that the variant was first detected in September 2021 in a number of countries.

Following internal discussions, the WHO classified it as a "variant under monitoring" (VUM) in November 2021.

According to the WHO's definition, a VUM is SARS-CoV-2 variant with genetic changes that are suspected to affect virus characteristics, which may pose a future risk, but evidence of phenotypic or epidemiological impact is currently unclear, thus requiring enhanced monitoring and repeat assessment pending new evidence.

Van Kerkhove explained that since the B.1.640 variant has many mutations, the WHO classified it as a VUM is to raise the public's awareness.

She reiterated that current Covid-19 vaccines do work against all variants that are circulating and are highly effective against preventing severe diseases and death.

"I think that's really important for the public to know ... when it is your turn, get vaccinated because it's really critical," she said.

Katherine O'Brien, director of the WHO's Immunization, Vaccines and Biologicals Department, said that B.1.640 is not a variant that is increasing in prevalence but is a small fraction of the strains that are circulating.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronFranceWorld Health Organization

First Published: Jan 07 2022 | 1:34 PM IST

Next Story